Agilent Technologies Collaborates with UC San Diego Researchers Seeking New Leukaemia Identification Methods
“Professor Trey Ideker’s team will explore a promising new approach for recognizing the mechanism that triggers leukaemia using multiple scientific disciplines. This could produce a powerful new tool for detection and treatment,” said Allan Kuchinsky, the Agilent Laboratories scientist sponsoring the Ideker Lab for the Agilent Foundation support.
“This gift from the Agilent Foundation will allow us to develop a system for analyzing proteomics data to map pathways, and for finding protein-network biomarkers of cancer,” Ideker said.
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.